Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Cash flows from operating activities
Net income	$ 2,806	$ 2,856
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation	389	377
Gain on sale of loans	(154)	(173)
Amortization of premium and accretion of discount on securities, net	62	131
Deferred income tax expense (benefit)	1	(106)
Provision for credit losses	56	99
Origination of loans held for sale	(6,166)	(10,584)
Proceeds from sales of loans held for sale	6,320	10,757
ESOP expense	118	126
Stock based compensation	26
Change in assets and liabilities:
Accrued interest receivable	(610)	(408)
Mortgage servicing rights	22	10
Other assets	381	411
Accrued interest payable	(227)	873
Accounts payable, accrued expenses and other liabilities	(646)	(143)
Net cash provided by operating activities	2,378	4,226
Cash flows from investing activities
Net change in loans	(24,664)	(21,967)
Purchase of investment securities available for sale	(3,026)	(6,030)
Principal paydowns from investment securities available for sale	6,508	7,043
Principal paydowns from investment securities held to maturity	51	95
Purchase of FHLB stock	(28)	(21)
Purchase of premises and equipment	(4,798)	(533)
Net cash used in investing activities	(25,957)	(21,413)
Cash flows from financing activities
Net change in deposits	19,203	(23,508)
Net change in advances from borrowers for taxes and insurance	(303)	(236)
Proceeds from issuance of common stock, net of costs		39,364
Repurchase of common stock	(137)
Loan to ESOP		(3,305)
Net cash provided by financing activities	18,763	12,315
Net decrease in cash and cash equivalents	(4,816)	(4,872)
Cash and cash equivalents - beginning of period	11,454	16,563
Cash and cash equivalents - end of period	6,638	11,691
Supplemental disclosures of cash flow information:
Cash paid for taxes	300	500
Cash paid for interest	$ 6,378	$ 3,803